Patents
Patents for C07B 59 - Introduction of isotopes of elements into organic compounds (2,678)
12/2002
12/27/2002WO2002102711A1 Method and apparatus for production and use of [11c] carbon monoxide in labeling synthesis
12/27/2002CA2451638A1 Deuterated n-substituted and .alpha.-substituted diphenylalkoxy acetic acid amino alkyl esters and medicaments containing these compounds
12/27/2002CA2448524A1 Method and apparatus for production and use of [11c] carbon monoxide in labeling synthesis
12/17/2002CA2085464C Using 5,10,15,10-tetrakis (r-carboxyphenyl)porphine for detecting and treating lung cancer
12/05/2002US20020182169 Polymer precursors of radiolabeled compounds, and methods of making and using the same
12/04/2002EP1062190B1 Method for producing [15 o] butanol and device for implementing said method
11/2002
11/26/2002CA2060330C Compositions and method for soft tissue tumors
11/21/2002US20020173666 Process for preparing a deuterated or tritiated compound
11/20/2002EP1017684B1 Contrasting agent for infarct and necrosis imaging
11/14/2002WO2002090298A2 Method for the synthesis of 18f marked compounds which are low in carriers
11/14/2002DE10123129A1 Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel Deuterated 3-piperidinopropiophenones and pharmaceutical compositions containing them
11/14/2002DE10121741A1 Verfahren zur Synthese trägerarmer ·18·F markierter Verbindungen Process for the synthesis of low carrier · 18 · F labeled compounds
11/12/2002US6479032 Calcitonin receptor binding reagents
11/07/2002WO2002088100A2 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
11/06/2002EP0711300B1 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
11/06/2002EP0630264B1 Ligands for improving metal chelate formation kinetics
11/05/2002US6475807 Mass-based encoding and qualitative analysis of combinatorial libraries
10/2002
10/31/2002WO2002085418A2 Tc and re labeler radioactive glycosylated octreotide derivatives
10/29/2002US6472422 Treating drug addiction
10/24/2002US20020155063 Injecting sample comprising a precursor chemical compound, into injection loop of a high performance liquid chromatograph (HPLC); injecting radiolabeling reagent into loop to react and form radiolabeled compound, isolating
10/01/2002US6458998 Naphthaleneureas as antidiabetic agents
10/01/2002US6458433 Isotope replacement; optical display
09/2002
09/19/2002US20020132763 Deuterated cyclosporine analogs and their use as immunomodulating agents
09/19/2002US20020131932 Radiopharmaceuticals for diagnosing alzheimer's disease
09/12/2002WO2002070020A2 Polymer precursors of radiolabeled compounds, and methods of making and using the same
09/12/2002CA2710031A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same
09/12/2002CA2709871A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same
09/10/2002US6447748 Benzamide compounds for cancer imaging and therapy
09/10/2002US6447747 Process for the preparation of radiopharmaceuticals
08/2002
08/29/2002US20020119096 Fluorination of proteins and peptides for F-18 positron emission tomography
08/21/2002EP1232164A1 Pre-cursor for radiodiagnostic agents and the production thereof
08/20/2002US6436365 Administration via catheter of radioactive metal complex to site of legion; treatment of athersclerosis; reduces undesired radioactive exposure of healthy tissue
08/15/2002WO2002044175A3 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit
08/14/2002CN1364158A Mutilin derivatives and their use as antibacterials
08/14/2002CN1364156A Novel naphthalene ureas as glucose uptake enhancers
08/07/2002EP0636183B1 Compositions and methods for protein structural determinations
08/07/2002CN1362405A Nitroso compound and use of it as spin catching agent
07/2002
07/25/2002US20020098148 Radiolabelled substituted carbonylaminobenzene derivatives which bind androgen recepotr
07/18/2002US20020094995 Modification of the molecular structure of dihydropyridine family drug containing one or more hydrogen atoms by deuterating one or more hydrogen atoms to deuterium atoms; improved activity over the known drug
07/17/2002CN1087725C Enhancement of the effect of drugs by deuteration
07/17/2002CN1087631C Radiolabeled peptides for diagnosis and therapy
07/10/2002EP0820312B1 Ternary radiopharmaceutical complexes
07/09/2002US6417384 Radioiodinated phospholipid ether analogs and methods of using the same
07/04/2002US20020086338 Compound for use in monitoring activities of free radicals
07/02/2002CA2040204C Chelating compounds and their use
06/2002
06/27/2002US20020082398 For use in diagnosis and therapy
06/19/2002EP1215204A2 Nitroso compounds and their use as spin traps
06/12/2002CN1353678A Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
06/06/2002WO2002044175A2 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit
05/2002
05/30/2002US20020065429 Radioiodinated phospholipid ether analogs and methods of using the same
05/10/2002WO2002036581A1 Radiopharmaceuticals for diagnosing alzheimer's disease
05/10/2002CA2424598A1 Radiopharmaceuticals for diagnosing alzheimer's disease
05/09/2002US20020055521 Analogs of cocaine
05/08/2002EP1202945A1 Methods for preparing perfluorinated [18 f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
05/02/2002EP1200451A1 Radiolabelled bisphosphonates and method
04/2002
04/24/2002EP1198454A1 Mutilin derivatives and their use as antibacterials
04/23/2002US6376697 Labelled phosphoinositides and analogues
04/23/2002US6376253 Cultivation of a microbial culture containing isotopically labeled amino acids
04/18/2002WO2002030937A2 Labeled resiniferatoxin derivatives for use in vanilloid receptor binding assay
04/17/2002EP1196427A2 Novel c-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof
04/17/2002CN1345249A Kit for radiolabeling proteins with yttrium-90
04/11/2002US20020042539 Such as tetraethyl-N-(m-trimethylsilylphenylethyl)amino-methylenebisphosphonate for palliative and curative treatment of bone disorders and breast cancer
04/10/2002EP1195168A2 Ternary radiopharmaceutical complexes
04/09/2002CA2298572C Deuterated cyclosporine analogs and their use as immunomodulating agents
04/04/2002US20020038858 Isotope replacement; optical display
04/03/2002EP1193271A2 Compositions and methods for protein structural determinations
04/02/2002US6365125 Using organotin compound
03/2002
03/27/2002EP1191033A2 Compositions and methods for protein structural determinations
03/26/2002US6362352 Medical diagnosis
03/19/2002US6358489 Fluorination of proteins and peptides for F-18 positron emission tomography
03/14/2002WO2002020434A1 Synthesis of 17f labeled fluoroalkanes
03/07/2002US20020028177 Synthesis of 17F labeled fluoroalkanes
03/06/2002CN1080127C Ternary radiopharmaceutical complexes
02/2002
02/27/2002EP1181271A2 Naphthalene ureas as glucose uptake enhancers
02/14/2002WO1995029669A3 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
02/13/2002EP0614379B1 Technetium-99m labeled peptides for imaging
01/2002
01/31/2002US20020012631 As imaging agents for the diagnosis of cardiovascular disorders such as thromboembolic disease or atherosclerosis, infectious disease and cancer
01/30/2002CN1078480C Somatostatin binding peptide-metal chelate conjugates
01/23/2002EP1173184A1 Rho-boronophenylalanine complexes with fructose and related carbohydrates and polyols
01/22/2002US6340578 High speed determination of three-dimensional structure using isotopes; polypeptide biosynthesis
01/16/2002EP1019095B1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
01/10/2002US20020004032 Macrocyclic chelants for metallopharmaceuticals
01/10/2002US20020004031 Process for therapeutic treatment of proliferative diseases
01/09/2002EP1169282A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
01/09/2002EP0792253B1 Production of [11C] methyl iodide
01/03/2002WO2002000603A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
01/03/2002CA2412568A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
01/02/2002EP1165834A1 High throughput screening method for determining enantioselectivity
01/01/2002US6335196 13C,15N ,2H labeled proteins for NMR structure determinations and their preparation
01/01/2002US6334997 Method of using deuterated calcium channel blockers
12/2001
12/11/2001US6329513 Cores for technetium radiopharmaceuticals
12/06/2001WO2001092188A1 Method for labeling with tritium
12/05/2001EP0835233B1 Composition and method for stabilizing radiolabeled organic compounds
11/2001
11/28/2001EP1156835A2 Kit for radiolabeling proteins with yttrium-90
11/14/2001CN1074766C Alkylaminobenzothiazole and -benzoxazole derivatives
11/01/2001US20010036965 Preventing transmission of a sexually transmitted disease, such as hiv, gonorrhea, syphilis; antifertility agents
10/2001
10/31/2001EP1148878A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors
10/23/2001US6307045 Reacting an organometallic compound with a halide ion under light irradiation conditions in the presence of a semiconductor catalyst with a photocatalytic activity.
10/18/2001WO2001077122A1 Ternary ligand complexes useful as radiopharmaceuticals
10/18/2001WO2001077102A1 Macrocyclic chelants for metallopharmaceuticals
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27